The 2017 AF Summit program provides a comprehensive review of atrial fibrillation (AF) ablation and evolving therapies that are shaping the field.
Earn up to 5.5 CME credits and 5.5 MOC points
Member Allied/Fellows In Training
*Non-Member Allied/Fellows In Training
*If you are a Non-Member Allied Professional / Fellow In Training, please Contact Us for special pricing. Please include your title, facility name and complete contact information.
AF01. Beyond PV Isolation for Persistent AF: What is the Answer?
Session Description: This session will review novel approaches to ablation of persistent AF, as well as, a presentation by the recipient of the Lectureship Award, Fred Morady, “My Perspective on Catheter Ablation of Persistent AF”.
AF02. New and Old Technologies for AF Ablation
Session Description: This session will provide an update on techniques and outcomes of AF ablation of persistent and long standing persistent atrial fibrillation.
AF03. More Unmet Challenges When it Comes to AF Ablation
Session Description: This session will center evolving areas in AF ablation incorporating risk modification, management of anticoagulants, and focus on best practice methods of AF ablation.
Upon completion of this educational activity, participants will be able to:
- Analyze the STAR AF Trial and how it has impacted the field
- Understand the implications of the Fire and Ice Trial
- Evaluate new tools and technologies that may impact the field
- Explain the scientific basis of persistent AF
- Assess non PV approaches
- Discuss how to maximize PV isolation
- Describe the role of risk factor modification
- Identify the role of AF ablation in asymptomatic patients
- Recognize when to say "No go" to AF ablation
Clinical Cardiac EPs
Directors of EP Labs
Stanley Nattel MD, FHRS
Montreal Heart Institute
David Spragg MD,FHRS
Johns Hopkins University
Vivek Reddy MD
Mount Sinai School of Medicine
New York, NY
Atul Verma MD, FHRS
Southlake Regional Health Centre
Fred Morady MD
University of Michigan
Ann Arbor, MI
Gregory Supple MD, FHRS
Hospital of the University of Pennsylvania
David Haines MD, FHRS
Royal Oak, MI
Hiroshi Nakagawa MD, PhD
University of Oklahoma
Oklahoma City, OK
Greogry Michaud MD, FHRS
Brigham and Women's Hospital
Josep Brugada Terradellas MD, PhD
Hospital Clinic - University of Barcelona
Gerhard Hindricks MD, PhD
Edward Gerstenfeld MD, FHRS
University of California - San Francisco
San Francisco, CA
Prashanthan Sanders MBBS, PhD, FHRS
University of Adelaide and Royal Adelaide Hospital
Abhishek Deshmukh MD
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA CREDIT DESIGNATION STATEMENT
The Heart Rhythm Society designates this enduring material for a maximum of 5.5 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.
ABIM MAINTENANCE OF CERTIFICATION (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
DISCLOSURE OF FACULTY’S COMMERCIAL RELATIONSHIP(S)
It is the policy of the Heart Rhythm Society to ensure balance, independent objectivity, and scientific rigor in all its certified educational activities. Everyone involved in the planning and participation of continuing medical education activities is required to disclose any real or apparent conflicts of interest related to the content in his/her presentation(s) and also disclose discussions of unlabeled/unapproved uses of drugs or devices during his/her presentation(s).
Faculty Discloure List PDF
REPORTING CONFLICT OF INTEREST OR BIAS IN A PRESENTATION
Allegations of conflict of interest and bias are taken seriously and are investigated by the Ethics Oversight Committee, Scientific Sessions Program Committee and/or the Education Committee. Your complaint will be referred to the appropriate committee, and you will be informed in writing of the outcome of its review and decision. Submit a confidential complaint by completing the form at http://www.hrsonline.org/About-HRS/Heart-Rhythm-Society-Governance/Conflict-of-Interest-Complaint-Form#axzz32C70AtsV or submit an email message to scientific.sessions@HRSonline.org.